Exploring Alzheimer's, Parkinson's, and Brain Health Solutions with Christer Rosén of Jupiter Neurosciences, Inc.

We sit down with Christer Rosén, Chairman, CEO and Founder of Jupiter Neurosciences, Inc., a clinical-stage biotech company developing therapies for brain inflammation and mitochondrial dysfunction. With decades of entrepreneurial experience, Christer shares his journey from computer science to pharmaceuticals and biotechnology, and his mission to create impactful treatments for neurological diseases such as Alzheimer's and Parkinson's.    Key Takeaways: 00:00 Introduction. 01:41 Christer shifts from computer science to biotech, founding EffRx Pharmaceuticals. 03:42 A patented micellar formulation achieves nine times higher bioavailability. 08:16 Biohackers stress eight hours of quality sleep for brain health. 10:10 Early ventures show the value of surrounding yourself with the best people. 13:55 Christer learns the value of doing your homework when opening a restaurant in the US.  15:41 True wealth for Christer is family and time with grandchildren. 17:26 A natural compound with strong data leads to a new nutraceutical line. 18:45 Nutraceuticals offer affordable access and broad patient benefits.   Resources Mentioned: Christer Rosén https://www.linkedin.com/in/christer-ros%C3%A9n-23ab083/ Jupiter Neurosciences, Inc. | LinkedIn https://www.linkedin.com/company/jupiterneurosciences/ Jupiter Neurosciences, Inc. | Website https://jupiterneurosciences.com/ EffRx Pharmaceuticals SA | Website  https://www.effrx.com/ National Institute on Aging | Website https://www.nia.nih.gov/ Murdoch Children's Research Institute https://www.mcri.edu.au/   Thanks for joining us for the latest episode of "Day in a Canoe." If you enjoyed this episode, please leave a 5-star review, and be sure to subscribe so you never miss any of our insightful conversations. If you'd like us to help you define what true wealth means to you, go to www.planningalt.com and take our assessment. Planning Alternatives is an investment advisory firm registered with the Securities and Exchange Commission. Any opinions expressed may not reflect those of Planning Alternatives.   #Biotech #NeuroScience #BrainHealth #Innovation #HealthTech